Role of AhR in regulating cancer stem cell–like characteristics in choriocarcinoma

References

• Powles T, Savage PM, Stebbing J, et al. A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia. Br J Cancer. 2007;96(5):732–737. PMID: 17299394. .
   PubMed Web of Science ®Google Scholar
• Seckl MJ, Sebire NJ, Fisher RA, et al. Gestational trophoblastic disease: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;10(24):39–50. PMID: 23999759.
   Google Scholar
• Soper JT, Evans AC, Conaway MR, et al. Evaluation of prognostic factors and staging in gestational trophoblastic tumor. Obstet Gynecol. 1994;84(6):969–973. PMID:7970479.
   PubMed Web of Science ®Google Scholar
• Taylor F, Short D, Winter MC, et al. A retrospective study to evaluate single agent methotrexate treatment in low risk gestational choriocarcinoma in the United Kingdom. Gynecol Oncol. 2015;136:258–263. PMID:25542400. .
   PubMed Web of Science ®Google Scholar
• Gilani MM, Fariba B, Behtash N, et al. The WHO score predicts treatment outcome in low risk gestational trophoblastic neoplasia patients treated with weekly intramuscular methotrexate. J Cancer Res Ther. 2013;9:38–43. PMID:23575072. .
   PubMed Web of Science ®Google Scholar
• Ngan HY. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Int Gynecol Cancer. 2004;14:202–205. PMID:15086715. .
   PubMed Web of Science ®Google Scholar
• Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997;3:730–737. PMID:9212098. .
   PubMed Web of Science ®Google Scholar
• Clarke MF, Dick JE, Dirks PB, et al. Cancer stem cells—perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Res. 2006;66:9339–9344. PMID:16990346. .
   PubMedGoogle Scholar
• AI-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Sci USA. 2003;100:3983–3988. PMID:12629218. .
   PubMed Web of Science ®Google Scholar
• Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature. 2004;432:396–401. PMID:15549107. .
   PubMed Web of Science ®Google Scholar
• Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature. 2007;445:111–115. PMID:17122771. .
   PubMed Web of Science ®Google Scholar
• Ho MM, Ng AV, Lam S, et al. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res. 2007;67:4827–4833. PMID:17510412. .
   PubMed Web of Science ®Google Scholar
• Abdullah LN, Chow EK. Mechanisms of chemoresistance in cancer stem cells. Clin Transl Med. 2013;2:3. PMID:23369605. .
   PubMedGoogle Scholar
• Bomken S, Fisher K, Heidenreich O, et al. Understanding the cancer stem cell. Br J Cancer. 2010;103:493–495. PMID:20664590. .
   Web of Science ®Google Scholar
• Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, cancer stem cells. Nature. 2001;414:105–111.
   PubMed Web of Science ®Google Scholar
• Winquist RJ, Furey BF, Boucher DM. Cancer stem cells as the relevant biomass for drug discovery. Curr Opin Pharmacol. 2010;10:385–390. PMID:20630801. .
   PubMed Web of Science ®Google Scholar
• Kewley RJ, Whitelaw ML, Chapman-Smith A. The mammalian basic helix-loop-helix/PAS family of transcriptional regulators. Int J Biochem Cell Biol. 2004;36:189–204. PMID:14643885. .
   PubMed Web of Science ®Google Scholar
• Kerzee JK, Ramos KS. Constitutive and inducible expression of Cyp1a1 and Cyp1b1 in vascular smooth muscle cells: role of the Ahr bHLH/PAS transcription factor. Circ Res. 2001;89(7):573–582. PMID:11577022.
   PubMed Web of Science ®Google Scholar
• Safe S, Lee SO, Jin UH. Role of the aryl hydrocarbon receptor in carcinogenesis and potential as a drug target. Toxicol Sci. 2013;135:1–16. PMID:23771949. .
   PubMed Web of Science ®Google Scholar
• Pollenz RS. The mechanism of AH receptor protein down-regulation (degradation) and its impact on AH receptor-mediated gene regulation. Chem Biol Interact. 2002;141:41–61. PMID:12213384. .
   PubMed Web of Science ®Google Scholar
• Cai JT, Peng TF, Liu HN, et al. Isolation, culture and identification of choriocarcinoma stem-like cells from the human choriocarcinoma cell-line JEG-3. Cell Physiol Biochem. 2016;38:1421–1432. PMID:27606814. .
   Google Scholar
• Choi EJ, Seo EJ, Kim DK, et al. FOXP1 functions as an oncogene in promoting cancer stem cell-like characteristics in ovarian cancer cells. Oncotarget. 2016;7:3506–3519. PMID:26654944. .
   PubMed Web of Science ®Google Scholar
• Huso TH, Resar LM. The high mobility group A1 molecular switch: turning on cancer – can we turn it off? Opin Ther Targets. 2014;18:541–553. PMID:24684280. .
   PubMed Web of Science ®Google Scholar
• Seo EJ, Kwon YW, Jang IH, et al. Autotaxin regulates maintenance of ovarican cancer stem cells through lysophosphatidic acid – mediated autocrine mechanism. Stem Cells. 2016;34:551–564. PMID:26800320. .
   PubMed Web of Science ®Google Scholar
• Standford EA, Wang Z, Novikov O, et al. The role of the aryl hydrocarbon receptor in the development of cells with the molecular and functional characteristics of cancer stem – like cells. BMC Biol. 2016;14:20. PMID:26984638. .
   PubMed Web of Science ®Google Scholar
• Abdullah AD, Alhoshani A, Heshan MK. Aryl hydrocarbon receptor/cytochrome P450 1A1 pathway mediates breast cancer stem cells expansion through PTEN inhibition and β-Catenin and Akt activation. Molecular Cancer. 2017;16:14. PMID:28103884. .
   PubMed Web of Science ®Google Scholar
• Standford EA, Ramirez-Cardenas, Alejandra, Wang Z., et al. Role for the Aryl hydrocarbon receptor and diverse ligands in oral squamous cell carcinoma migration and tumorigenesis. Mol Cancer Res. 2016;14:696–706. PMID: 27130942. .
   PubMed Web of Science ®Google Scholar
• Zhao S, Kanno Y, Nakayama M, et al. Activation of the aryl hydrocarbon receptor represses mammosphere formation in MCF-7 cells. Cancer Lett. 2012;317:192–198. PMID:22123295. .
   PubMed Web of Science ®Google Scholar
• Hall JM, Barhoover MA, Kazmin D, et al. Activation of the aryl-hydrocarbon receptor inhibits invasive and metastatic features of human breast cancer cells and promotes breast cancer cell differentiation. Mol Endocrinol. 2010;24(2):359–369. PMID: 20032195. .
   PubMedGoogle Scholar
• Prud’homme GJ, Glinka Y, Toulina A, et al. Breast cancer stem-like cells are inhibited by a non-toxic aryl hydrocarbon receptor agonist. Plos One. 2010;5:e13831. PMID:21072210. .
   PubMed Web of Science ®Google Scholar
• Holland JD, Klaus A, Garratt AN, et al. Wnt signaling in stem and caner stem cells. Curr Opin Cell Biol. 2013;25:254–264. PMID:23347562. .
   PubMed Web of Science ®Google Scholar
• Reya T, Clevers H. Wnt signaling in stem cells and cancer. Nature. 2005;434:843–850. PMID:15829953. .
   PubMed Web of Science ®Google Scholar
• Bisson I, Prowse DM. WNT signaling regulates self-renewal and differentiation of prostate cancer cells with stem cell characteristics. Cell Res. 2009;19:683–697. PMID:19365403. .
   PubMed Web of Science ®Google Scholar
• Fischer KR, Durrans A, Lee S, et al. Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance. Nature. 2015;527:472–476. PMID:26560033. .
   PubMed Web of Science ®Google Scholar
• Ebert B, Seidel A, Lampen A. Identification of BCRP as transporter of benzo[a]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists. Carcinogenesis. 2005;26(10):1754–1763. PMID:15917307. .
   PubMed Web of Science ®Google Scholar
• To KK, Yu L, Liu S, et al. Constitutive AhR activation leads to concomitant ABCG2-mediated multidrug resistance in cisplatin-resistant esophageal carcinoma cells. Mol Carcinog. 2012;51(6):449–464. PMID:21678497. .
   PubMed Web of Science ®Google Scholar
• Tan KP, Wang B, Yang M, et al. Aryl hydrocarbon receptor (AHR) is a transcriptional activator of the human breast cancer resistance protein (BCRP/ABCG2). Mol Pharmacol. 2010;78(2):175–185. PMID:20460431. .
   PubMed Web of Science ®Google Scholar